SURVEY OF QUALITY OF LIFE AND ASSOCIATED FACTORS IN CANCER PATIENTS RECEIVING PALLIATIVE CARE AT THE GENERAL SURGERY DEPARTMENT – NGHE AN FRIENDSHIP GENERAL HOSPITAL
Main Article Content
Abstract
Objective: To evaluate health-related quality of life (HRQoL) among palliative oncology patients and identify associated factors. Materials and Methods: Cross-sectional study of 105 patients (Oct 2024–May 2025). HRQoL assessed by EORTC QLQ‑C30 (v3). Univariate tests and Gamma‑log GLM for independent associations. Results: Mean age 68.0; ~74% male; 80% stage III–IV; PS2 45.7%. Mean scores: symptom 35.3; functioning 51.8; financial 54.3; global health 40.2; summary 46.6. Independent correlates of higher HRQoL: marriage (+20.2%), time since diagnosis <6 months (+9.4%) and 6–12 months (+20.8%), PS ≤2 (+19.8%); ongoing/any anti‑cancer therapy associated with lower HRQoL (−7.8%); Conclusion: HRQoL was poor overall, particularly physical/role domains. Social support, good performance status, and shorter time since diagnosis were favorable. Early palliative integration and family support are recommended.
Article Details
Keywords
EORTC QLQ C30; palliative care; quality of life; advanced cancer.chuyển
References
2. Quinten C, Martinelli F, Coens C, et al. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 2014;120(2):302-311. doi:10.1002/cncr.28382
3. Nayak M, George A, Vidyasagar M, et al. Quality of life among cancer patients. Indian J Palliat Care. 2017;23(4):445. doi:10.4103/IJPC. IJPC_82_17
4. Laird BJA, Fallon M, Hjermstad MJ, et al. Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response. J Clin Oncol. 2016;34(23):2769-2775. doi:10.1200/ JCO.2015.65.7742
5. Jatoi A, Novotny P, Cassivi S, et al. Does Marital Status Impact Survival and Quality of Life in Patients with Non-Small Cell Lung Cancer? Observations from the Mayo Clinic Lung Cancer Cohort. Oncologist. 2007;12(12):1456-1463. doi:10.1634/theoncologist.12-12-1456
6. Prigerson HG, Bao Y, Shah MA, et al. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncol. 2015;1(6): 778-784. doi:10.1001/jamaoncol. 2015.2378
7. Temel JS, Greer JA, Muzikansky A, et al. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer. New England Journal of Medicine. 2010;363(8):733-742. doi:10.1056/NEJMoa1000678